Co-Authors
This is a "connection" page, showing publications co-authored by Wen-Chun Liu and Randy Albrecht.
Connection Strength
0.576
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med. 2021 08 17; 2(8):100369.
Score: 0.060
-
Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression. Hum Pathol. 2021 08; 114:110-119.
Score: 0.059
-
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021 08; 5(8):815-829.
Score: 0.059
-
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021 08; 34(8):1456-1467.
Score: 0.059
-
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 2021 05 13; 184(10):2618-2632.e17.
Score: 0.059
-
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine. Vaccines (Basel). 2020 Dec 17; 8(4).
Score: 0.057
-
Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
Score: 0.057
-
An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol. 2020 09; 58(1):e108.
Score: 0.056
-
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 10; 586(7827):113-119.
Score: 0.056
-
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020 05 28; 181(5):1036-1045.e9.
Score: 0.055